NEFL and amyotrophic lateral sclerosis: Given the number of pseudolongitudinal CSF NfL data points analyzed in this study, our findings provide strong evidence for the ability of CSF NfL to reflect the rate of neuroaxonal degeneration in ALS and its potential to serve as a biomarker in future clinical trials.